Posts Tagged ‘rhabdomyolysis’

June 8th, 2011

FDA Recommends Limiting Use of High-Dose Simvastatin

The FDA today recommended significant limitations in the use of high-dose (80 mg) simvastatin because of the increased risk for myopathy. The FDA said the 80-mg dose should be used only in people who have been taking the high dose for at least one year and have had no evidence of myopathy. The high dose […]